NCT00699088

Brief Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Balance® Microplasty™ Hip System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2005

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 13, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 17, 2008

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

June 21, 2017

Status Verified

June 1, 2017

Enrollment Period

8.2 years

First QC Date

June 13, 2008

Last Update Submit

June 19, 2017

Conditions

Keywords

Total Hip ArthroplastyTotal Hip ReplacementMinimally InvasiveMicroplasty

Outcome Measures

Primary Outcomes (1)

  • Harris Hip Score

    5 years

Secondary Outcomes (1)

  • Incidence of revisions and removals

    5 Years

Study Arms (1)

Balance® Microplasty™ Hip System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients requiring relief from painful or disabling joint disease

You may qualify if:

  • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid arthritis.
  • Correction of functional deformity.
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
  • Revision of previously failed femoral head resurfacing component

You may not qualify if:

  • Absolute contraindications include:
  • infection,
  • sepsis,
  • osteomyelitis.
  • Relative contraindications include:
  • uncooperative patient or patient with neurologic disorders who are incapable of following directions,
  • osteoporosis,
  • metabolic disorders which may impair bone formation,
  • osteomalacia,
  • distant foci of infections which may spread to the implant site,
  • rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
  • vascular insufficiency, muscular atrophy, or neuromuscular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Chicago

Chicago, Illinois, 60640, United States

Location

Allegheny Health- Orthopedic Division

Pittsburgh, Pennsylvania, 15212, United States

Location

Orthopedic Specialty Clinic

Fredericksburg, Virginia, 22401, United States

Location

Orthopaedic & Sports Medicine Clinic of Monroe

Monroe, Wisconsin, 53566, United States

Location

MeSH Terms

Conditions

Osteoarthritis, HipArthritis, RheumatoidOsteonecrosis

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Russell Schenck, PhD

    Director, Clinical Research, Biomet Orthopedics, LLC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2008

First Posted

June 17, 2008

Study Start

January 1, 2005

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

June 21, 2017

Record last verified: 2017-06

Locations